Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 12.63
(0.96%)
CNY 12.63
(0.96%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 285.82 Million CNY | 10.02% |
| 2022 | 238.43 Million CNY | -9.84% |
| 2021 | 264.45 Million CNY | 6.37% |
| 2020 | 248.62 Million CNY | -26.38% |
| 2019 | 337.69 Million CNY | 25.83% |
| 2018 | 268.37 Million CNY | 14.12% |
| 2017 | 235.16 Million CNY | 27.1% |
| 2016 | 185.02 Million CNY | 48.71% |
| 2015 | 124.42 Million CNY | 1.14% |
| 2014 | 123.01 Million CNY | 3.98% |
| 2013 | 118.3 Million CNY | 6.3% |
| 2012 | 111.28 Million CNY | 34.35% |
| 2011 | 82.83 Million CNY | 36.29% |
| 2010 | 60.78 Million CNY | 19.53% |
| 2009 | 50.85 Million CNY | 77.62% |
| 2008 | 28.62 Million CNY | 60.11% |
| 2007 | 17.88 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 50.95 Million CNY | -32.97% |
| 2024 Q2 | 66.16 Million CNY | 29.86% |
| 2024 Q3 | 64.52 Million CNY | -0.77% |
| 2023 Q2 | 66.94 Million CNY | 15.49% |
| 2023 FY | 262.32 Million CNY | 10.02% |
| 2023 Q4 | 76.01 Million CNY | 16.36% |
| 2023 Q1 | 57.96 Million CNY | -11.15% |
| 2023 Q3 | 65.32 Million CNY | -2.42% |
| 2022 Q1 | 61.88 Million CNY | 0.89% |
| 2022 Q4 | 65.23 Million CNY | 5.13% |
| 2022 Q2 | 49.26 Million CNY | -20.4% |
| 2022 Q3 | 62.04 Million CNY | 25.96% |
| 2022 FY | 238.43 Million CNY | -9.84% |
| 2021 Q4 | 61.34 Million CNY | 6.3% |
| 2021 Q3 | 57.7 Million CNY | -20.21% |
| 2021 Q2 | 72.32 Million CNY | -1.03% |
| 2021 Q1 | 73.07 Million CNY | -11.63% |
| 2021 FY | 264.45 Million CNY | 6.37% |
| 2020 Q3 | 67.45 Million CNY | 36.35% |
| 2020 FY | 248.62 Million CNY | -26.38% |
| 2020 Q4 | 82.69 Million CNY | 22.59% |
| 2020 Q2 | 49.47 Million CNY | 0.95% |
| 2020 Q1 | 49 Million CNY | -66.98% |
| 2019 Q3 | 56.79 Million CNY | -6.34% |
| 2019 FY | 337.69 Million CNY | 25.83% |
| 2019 Q1 | 71.83 Million CNY | -0.02% |
| 2019 Q4 | 148.42 Million CNY | 161.34% |
| 2019 Q2 | 60.63 Million CNY | -15.58% |
| 2018 Q3 | 70.29 Million CNY | -10.75% |
| 2018 Q4 | 71.84 Million CNY | 2.21% |
| 2018 FY | 268.37 Million CNY | 14.12% |
| 2018 Q2 | 78.75 Million CNY | 65.85% |
| 2018 Q1 | 47.48 Million CNY | -31.03% |
| 2017 FY | 235.16 Million CNY | 27.1% |
| 2017 Q1 | 47.01 Million CNY | -37.05% |
| 2017 Q2 | 66.68 Million CNY | 41.84% |
| 2017 Q3 | 52.61 Million CNY | -21.1% |
| 2017 Q4 | 68.85 Million CNY | 30.86% |
| 2016 Q4 | 74.68 Million CNY | 73.26% |
| 2016 FY | 185.02 Million CNY | 48.71% |
| 2016 Q2 | 38.24 Million CNY | 31.94% |
| 2016 Q1 | 28.98 Million CNY | -14.44% |
| 2016 Q3 | 43.1 Million CNY | 12.69% |
| 2015 Q4 | 33.88 Million CNY | 5.11% |
| 2015 FY | 124.42 Million CNY | 1.14% |
| 2015 Q3 | 32.23 Million CNY | -3.33% |
| 2015 Q2 | 33.34 Million CNY | 33.61% |
| 2015 Q1 | 24.95 Million CNY | -30.87% |
| 2014 Q3 | 29.74 Million CNY | -6.18% |
| 2014 Q4 | 36.1 Million CNY | 21.38% |
| 2014 FY | 123.01 Million CNY | 3.98% |
| 2014 Q1 | 25.46 Million CNY | -14.16% |
| 2014 Q2 | 31.7 Million CNY | 24.48% |
| 2013 Q3 | 30.02 Million CNY | 2.71% |
| 2013 Q2 | 29.22 Million CNY | -0.53% |
| 2013 Q1 | 29.38 Million CNY | -5.16% |
| 2013 FY | 118.3 Million CNY | 6.3% |
| 2013 Q4 | 29.66 Million CNY | -1.17% |
| 2012 Q1 | 26.35 Million CNY | 19.0% |
| 2012 Q2 | 27.71 Million CNY | 5.15% |
| 2012 Q3 | 26.23 Million CNY | -5.36% |
| 2012 Q4 | 30.98 Million CNY | 18.12% |
| 2012 FY | 111.28 Million CNY | 34.35% |
| 2011 FY | 82.83 Million CNY | 36.29% |
| 2011 Q2 | 22.31 Million CNY | 27.68% |
| 2011 Q3 | 20.88 Million CNY | -6.41% |
| 2011 Q4 | 22.14 Million CNY | 6.05% |
| 2011 Q1 | 17.47 Million CNY | 9.45% |
| 2010 FY | 60.78 Million CNY | 19.53% |
| 2010 Q2 | 14.07 Million CNY | -18.09% |
| 2010 Q3 | 13.54 Million CNY | -3.74% |
| 2010 Q4 | 15.97 Million CNY | 17.88% |
| 2010 Q1 | 17.18 Million CNY | 0.0% |
| 2009 FY | 50.85 Million CNY | 77.62% |
| 2008 FY | 28.62 Million CNY | 60.11% |
| 2007 FY | 17.88 Million CNY | 0.0% |